Although FOXD1 is extensively marked by H3K27me3 in melanocytes, we did not observe significant increases in FOXD1 expression in two in vivo melanoma models with PRC2 loss of function, possibly because the epigenetic programs that repress FOXD1 expression extend beyond H3K27me3. This evidence concerns the gene FOXD1 and melanoma.